Spectrum of paraneoplastic disease associated with lymphoma

Neurology

Volumn 76, Issue 8, 2011, Pages 705-710

  Briani, C ^a   Vitaliani, R ^b   Grisold, W ^c   Honnorat, J ^d,e   Graus, F ^f   Antoine, J C ^g   Bertolini, G ^h   Giometto, B ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b OSPEDALE CA FONCELLO   (Italy)

^c KAISER FRANZ JOSEF HOSPITAL   (Austria)

^d HÔPITAL NEUROLOGIQUE   (France)

^e UNIVERSITÉ LYON 1   (France)

^f HOSPITAL CLÍNIC   (Spain)

^g SERVICE DE NEUROLOGIE   (France)

^h MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; THERMORESISTANT ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CEREBELLUM DEGENERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PARANEOPLASTIC SYNDROME; PERIPHERAL NERVOUS SYSTEM; PREVALENCE; PRIORITY JOURNAL; RADICULOPATHY;

EID: 79952023928     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820d62eb     Document Type: Article

References (19)

1. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-1554. (Pubitemid 37255041)
2. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-1140. (Pubitemid 39005770)
3. Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, PNS Euronetwork. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 2010;67:330-335.
4. Hughes RA, Bouche P, Cornblath DR, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-332.
5. Briani C, Zambello R, Cavallaro T, et al. Improvement of peripheral nervous system manifestations of B-cell non-Hodgkin's lymphoma after Rituximab therapy. J Peripher Nerv Syst 2009;14:146-148.
6. Graus F, Dalmau J, Valldeoriola F, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61. (Pubitemid 27128977)
7. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003;126:1409-1418.
8. Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003;60:230-234.
9. Herrero S, Cantalapiedra A, Pérez-Oteyza J, Bellas C, Gobernado J, Odriozola J. Mantle cell lymphoma with amyotrophic lateral sclerosis (motor neuron disease). Haematologica 1998;83:382-383. (Pubitemid 28217865)
10. Younger DS, Rowland LP, Latov N, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 1991;29:78-86.
11. Louis ED, Hanley AE, Brannagan TH, et al. Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy. Muscle Nerve 1996;19:1334-1337. (Pubitemid 26313831)
12. Gordon PH, Rowland LP, Younger DS, et al. Lymphoproliferative disorders and motor neuron disease: an update. Neurology 1997;48:1671-1678.
13. Nobile-Orazio E, Carpo M, Meucci N. Are there immunologically treatable motor neuron diseases? Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2(suppl 1):S23-S30.
14. Ito H, Latov N. Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNAc and Gal(beta 1-3)GlcNAc. J Neuroimmunol 1988;19:245-253.
15. Levine T, Pestronk A, Florence J, et al. Peripheral neuropathies in Waldenström's macroglobulinaemia. J Neurol Neurosurg Psychiatry 2006;77:224-228.
16. Ansell SM, Kyle RA, Reeder CB, et al. Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clin Proc 2010;85:824-33.
17. Viala K, Béhin A, Maisonobe T, et al. Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry 2008;79:778-782.
18. Hughes RA, Britton T, Richards M. Effects of lymphoma on the peripheral nervous system. J R Soc Med 1994;87:526-530. (Pubitemid 24285563)
19. Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK. Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol 1977;1:72-78.